Skip to content

Clinical trials

Completed Appendiceal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Appendiceal Neoplasms Status: Completed Country / region: United States Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20022
20033
20041
20051
20073
20081
20091
20101
20111
20141
20162
20171
20181
20201
20214
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
Wake Forest University Health Sciences5
Dartmouth-Hitchcock Medical Center2
M.D. Anderson Cancer Center2
Memorial Sloan Kettering Cancer Center2
NYU Langone Health2
Albert Einstein College of Medicine1
Case Comprehensive Cancer Center1
Cybrexa Therapeutics1
Delcath Systems Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Appendiceal Neoplasms36
Stomach Neoplasms25
Colonic Neoplasms23
Pancreatic Neoplasms21
Esophageal Neoplasms19
Rectal Neoplasms19
Anus Neoplasms16
Carcinoma, Hepatocellular16
Gallbladder Neoplasms16
Bile Duct Neoplasms15

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.